These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

614 related items for PubMed ID: 19546819

  • 1. Outcome for patients with malignant pleural mesothelioma referred for Trimodality therapy in Western Australia.
    Hasani A, Alvarez JM, Wyatt JM, Bydder S, Millward M, Byrne M, Musk AW, Nowak AK.
    J Thorac Oncol; 2009 Aug; 4(8):1010-6. PubMed ID: 19546819
    [Abstract] [Full Text] [Related]

  • 2. Trimodality strategy for treating malignant pleural mesothelioma: results of a feasibility study of induction pemetrexed plus cisplatin followed by extrapleural pneumonectomy and postoperative hemithoracic radiation (Japan Mesothelioma Interest Group 0601 Trial).
    Hasegawa S, Okada M, Tanaka F, Yamanaka T, Soejima T, Kamikonya N, Tsujimura T, Fukuoka K, Yokoi K, Nakano T.
    Int J Clin Oncol; 2016 Jun; 21(3):523-30. PubMed ID: 26577445
    [Abstract] [Full Text] [Related]

  • 3. Pleurectomy/decortication is superior to extrapleural pneumonectomy in the multimodality management of patients with malignant pleural mesothelioma.
    Lang-Lazdunski L, Bille A, Lal R, Cane P, McLean E, Landau D, Steele J, Spicer J.
    J Thorac Oncol; 2012 Apr; 7(4):737-43. PubMed ID: 22425923
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Accelerated hemithoracic radiation followed by extrapleural pneumonectomy for malignant pleural mesothelioma.
    de Perrot M, Feld R, Leighl NB, Hope A, Waddell TK, Keshavjee S, Cho BC.
    J Thorac Cardiovasc Surg; 2016 Feb; 151(2):468-73. PubMed ID: 26614413
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Bilateral thoracoscopy, mediastinoscopy and laparoscopy, in addition to CT, MRI and PET imaging, are essential to correctly stage and treat patients with mesothelioma prior to trimodality therapy.
    Alvarez JM, Hasani A, Segal A, Sterret G, Millward M, Nowak A, Musk W, Bydder S.
    ANZ J Surg; 2009 Oct; 79(10):734-8. PubMed ID: 19878170
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Pleurectomy/decortication, hyperthermic pleural lavage with povidone-iodine followed by adjuvant chemotherapy in patients with malignant pleural mesothelioma.
    Lang-Lazdunski L, Bille A, Belcher E, Cane P, Landau D, Steele J, Taylor H, Spicer J.
    J Thorac Oncol; 2011 Oct; 6(10):1746-52. PubMed ID: 21876457
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Trimodality management of malignant pleural mesothelioma.
    Maggi G, Casadio C, Cianci R, Rena O, Ruffini E.
    Eur J Cardiothorac Surg; 2001 Mar; 19(3):346-50. PubMed ID: 11251277
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Miliary mesothelioma: a new clinical and radiological presentation in mesothelioma patients with prolonged survival after trimodality therapy.
    Purek L, Laroumagne S, Dutau H, Maldonado F, Astoul P.
    J Thorac Oncol; 2011 Oct; 6(10):1753-6. PubMed ID: 21918389
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Staging of patients after extrapleural pneumonectomy for malignant pleural mesothelioma--institutional review and current update.
    Cao C, Krog Andvik SK, Yan TD, Kennedy C, Bannon PG, McCaughan BC.
    Interact Cardiovasc Thorac Surg; 2011 May; 12(5):754-7. PubMed ID: 21303872
    [Abstract] [Full Text] [Related]

  • 20. Trimodality therapy for malignant pleural mesothelioma: results from an EORTC phase II multicentre trial.
    Van Schil PE, Baas P, Gaafar R, Maat AP, Van de Pol M, Hasan B, Klomp HM, Abdelrahman AM, Welch J, van Meerbeeck JP, European Organisation for Research and Treatment of Cancer (EORTC) Lung Cancer Group.
    Eur Respir J; 2010 Dec; 36(6):1362-9. PubMed ID: 20525721
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.